Literature DB >> 1333923

Cystic ovaries in women affected with hereditary angioedema.

R Perricone1, N Pasetto, C De Carolis, E Vaquero, G Noccioli, A E Panerai, L Fontana.   

Abstract

Polycystic ovary (PCO) syndrome is biochemically characterized by abnormal gonadotropin secretion and polycystic ovaries associated with increase in size and functional activity of stromal tissue; multifollicular ovaries (MFO) are defined by the presence of multiple cysts with no increase in stromal tissue. A central (hypothalamic-pituitary) abnormality, including high plasma beta-endorphin (BE) concentrations without simultaneous elevation of ACTH, was reported for subjects with PCO syndrome. Since we have found the presence of high plasma BE concentrations in hereditary angioedema (HANE) during attacks as well as during symptom-free periods, we studied, by means of pelvic ultrasound scanning employed to determine the prevalence of PCO and of MFO, 13 women of reproductive age affected with HANE who were not on oral contraceptives. We have found PCO in 5/13 (38.4%) and MFO in 7/13 (53.8%) HANE patients. Nine patients had oligomenorrhoea (five with PCO, three with MFO, one with normal ovaries), five (three with PCO, two with MFO) were hirsute and only one (with MFO) had weight loss. No patient was obese. Mean plasma LH, testosterone, prolactin, cortisol and ACTH concentrations were normal, while FSH was significantly reduced and LH/FSH ratio increased. BE concentrations were significantly high in all the patients studied. Our results clearly demonstrate that women with HANE frequently have cystic ovaries (polycystic or multifollicular) in the presence of high BE concentrations.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1333923      PMCID: PMC1554562          DOI: 10.1111/j.1365-2249.1992.tb05858.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE.

Authors:  V H DONALDSON; R R EVANS
Journal:  Am J Med       Date:  1963-07       Impact factor: 4.965

2.  The polycystic ovary. I. Clinical and histologic features.

Authors:  J W GOLDZIEHER; J A GREEN
Journal:  J Clin Endocrinol Metab       Date:  1962-03       Impact factor: 5.958

3.  Complement, complement activation and anaphylatoxins in human ovarian follicular fluid.

Authors:  R Perricone; C de Carolis; C Moretti; E Santuari; G de Sanctis; L Fontana
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

4.  Methodological problems and clinical validity of an ACTH radioimmunoassay method applied to extracted plasma samples.

Authors:  A R Genazzani; F Fraioli; C Conti; P Fioretti
Journal:  J Nucl Biol Med       Date:  1974-04

5.  A simple diagnostic test for hereditary angioneurotic edema.

Authors:  J S Fong; R A Good; H Gewurz
Journal:  J Lab Clin Med       Date:  1970-11

Review 6.  Interactions between the neuroendocrine and immune systems: common hormones and receptors.

Authors:  D A Weigent; J E Blalock
Journal:  Immunol Rev       Date:  1987-12       Impact factor: 12.988

7.  Increased plasma beta-endorphin levels in hereditary angioedema.

Authors:  R Perricone; C Moretti; C De Carolis; G De Sanctis; L Gnessi; A Fabbri; F Fraioli; A E Panerai; L Fontana
Journal:  Immunopharmacology       Date:  1989 Sep-Oct

8.  Elevated levels of plasma beta-endorphin and gamma 3-melanocyte stimulating hormone in the polycystic ovary syndrome.

Authors:  J Wortsman; W B Wehrenberg; J R Gavin; J P Allen
Journal:  Obstet Gynecol       Date:  1984-05       Impact factor: 7.661

9.  Polycystic ovaries--a common finding in normal women.

Authors:  D W Polson; J Adams; J Wadsworth; S Franks
Journal:  Lancet       Date:  1988-04-16       Impact factor: 79.321

10.  The role of ultrasound in the study of polycystic ovarian disease.

Authors:  L Parisi; M Tramonti; S Casciano; A Zurli; O Gazzarrini
Journal:  J Clin Ultrasound       Date:  1982-04       Impact factor: 0.910

View more
  3 in total

1.  Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond.

Authors:  Angelo Agostoni; Emel Aygören-Pürsün; Karen E Binkley; Alvaro Blanch; Konrad Bork; Laurence Bouillet; Christoph Bucher; Anthony J Castaldo; Marco Cicardi; Alvin E Davis; Caterina De Carolis; Christian Drouet; Christiane Duponchel; Henriette Farkas; Kálmán Fáy; Béla Fekete; Bettina Fischer; Luigi Fontana; George Füst; Roberto Giacomelli; Albrecht Gröner; C Erik Hack; George Harmat; John Jakenfelds; Mathias Juers; Lajos Kalmár; Pál N Kaposi; István Karádi; Arianna Kitzinger; Tímea Kollár; Wolfhart Kreuz; Peter Lakatos; Hilary J Longhurst; Margarita Lopez-Trascasa; Inmaculada Martinez-Saguer; Nicole Monnier; István Nagy; Eva Németh; Erik Waage Nielsen; Jan H Nuijens; Caroline O'grady; Emanuela Pappalardo; Vincenzo Penna; Carlo Perricone; Roberto Perricone; Ursula Rauch; Olga Roche; Eva Rusicke; Peter J Späth; George Szendei; Edit Takács; Attila Tordai; Lennart Truedsson; Lilian Varga; Beáta Visy; Kayla Williams; Andrea Zanichelli; Lorenza Zingale
Journal:  J Allergy Clin Immunol       Date:  2004-09       Impact factor: 10.793

Review 2.  Managing the female patient with hereditary angioedema.

Authors:  Aleena Banerji; Marc Riedl
Journal:  Womens Health (Lond)       Date:  2016-03-15

3.  Consider Hereditary Angioedema in the Differential Diagnosis for Unexplained Recurring Abdominal Pain.

Authors:  Kyle Staller; Anthony Lembo; Aleena Banerji; Jonathan A Bernstein; Eric D Shah; Marc A Riedl
Journal:  J Clin Gastroenterol       Date:  2022-08-15       Impact factor: 3.174

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.